Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOOV Head Lice Treatment in Primary School Children
NCT00381082Phase 3Completed
- Sponsor
- UniQuest
- Start
- Sep 2004
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Moov in pediculosis (3 arms), sponsored by UniQuest. Primary endpoint: Absence of live head lice one week after the last treatment at 21 days. Started Sep 2004; status: completed.
02
Drugs
Moov
03
Conditions
pediculosis
Beyond the preview
Go deeper on NCT00381082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00381082.